Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|January 1, 1977
Phase II studies of polychemotherapy regimens in small cell lung cancerR T Eagan, D T Carr, R E Lee, et al.
Neurology|July 1, 1987
Delayed leukoencephalopathy in survivors with small cell lung cancerN K So, B P O'Neill, S Frytak, et al.
Mayo Clinic Proceedings|December 1, 1985
Magnetic resonance imaging for neurotoxicity in long-term survivors of carcinomaS Frytak, F Earnest, B P O'Neill, et al.
Cancer Treatment Reports|August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lungJ C Britell, R T Eagan, J N Ingle, et al.
Cancer Treatment Reports|January 1, 1977
Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapyD L Ahmann, M J O'Connell, H F Bisel, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanomaE T Creagan, D L Ahmann, H J Long, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapyR T Eagan, T R Fleming, R E Lee, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|January 1, 1977
Phase II studies of polychemotherapy regimens in small cell lung cancerR T Eagan, D T Carr, R E Lee, et al.
Neurology|July 1, 1987
Delayed leukoencephalopathy in survivors with small cell lung cancerN K So, B P O'Neill, S Frytak, et al.
Mayo Clinic Proceedings|December 1, 1985
Magnetic resonance imaging for neurotoxicity in long-term survivors of carcinomaS Frytak, F Earnest, B P O'Neill, et al.
Cancer Treatment Reports|August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lungJ C Britell, R T Eagan, J N Ingle, et al.
Cancer Treatment Reports|January 1, 1977
Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapyD L Ahmann, M J O'Connell, H F Bisel, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanomaE T Creagan, D L Ahmann, H J Long, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapyR T Eagan, T R Fleming, R E Lee, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Pageof 11